Lung Cancer Medical Strategy Lead

AstraZeneca plc; Gaithersburg (MD); In loco; USD 150.000 - 225.000; Tempo pieno

Vantaggi offerti da questo lavoro

401(k) plan

Health benefits

Descrizione del lavoro

AstraZeneca plc in Gaithersburg, MD, seeks a leader to shape the US medical strategy for lung cancer, translating data into practice-changing insights for physicians and health systems. You will guide evidence plans, ensure scientific rigor, and engage across Medical, Sales, and Marketing teams to elevate patient care.

The role emphasizes cross-functional training, external engagement, and governance, with a focus on accelerating evidence generation and improving outcomes for patients in the US

Competenze

• Bachelor's Degree required in life sciences or related field.
• Experience in pharmaceutical industry and Medical Affairs preferred.
• Desirable: Advanced scientific degree.

Mansioni

• Lead US medical strategy for lung cancer in alignment with clinical needs and brand objectives.
• Coordinate evidence generation and synthesize insights to influence strategy.
• Design and deliver training to strengthen scientific fluency across teams.
• Contribute to policy, compliance, and governance of medical activities.
• Build relationships with healthcare professionals and external experts.
• Drive operational excellence and innovation in US Medical Affairs.
• Lead targeted research and produce data-driven reports for leadership.
• Collaborate with Market Access, Compliance and Commercial to inform access strategies.

Conoscenze

Medical Affairs experience

Cross-functional collaboration

Formazione

Bachelor's Degree

Advanced scientific degree

Descrizione del lavoro

AstraZeneca plc in Gaithersburg, MD, seeks a leader to shape the US medical strategy for lung cancer, translating data into practice-changing insights for physicians and health systems. You will guide evidence plans, ensure scientific rigor, and engage across Medical, Sales, and Marketing teams to elevate patient care.

The role emphasizes cross-functional training, external engagement, and governance, with a focus on accelerating evidence generation and improving outcomes for patients in the US